Question 1

Does UBS Group own MRKR stock?

Accepted Answer

Yes. As of its Q2 2026 13F, UBS Group holds 8,150 shares of MRKR (Marker Therapeutics), worth $11,981.

Question 2

How many shares of MRKR does UBS Group own?

Accepted Answer

As of its Q2 2026 13F, UBS Group holds 8,150 shares of MRKR (Marker Therapeutics).

Question 3

What is UBS Group's MRKR position worth?

Accepted Answer

As of its Q2 2026 13F, UBS Group's MRKR position is worth $11,981.

Question 4

Is UBS Group buying or selling MRKR?

Accepted Answer

In Q2 2026, UBS Group reduced its MRKR position by 24,219 shares (-74.8%).

Question 5

When did UBS Group first buy MRKR?

Accepted Answer

UBS Group first reported MRKR in its Q1 2023 13F and has listed it in 11 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	8,150	-74.8%	$11,981	0.0%	$1.47	0
2026-Q1	Decreased	32,369	-81.4%	$42,080	0.0%	$1.30	0
2025-Q4	Increased	174,026	+2903.6%	$259,299	0.0%	$1.49	25
2025-Q3	Increased	5,794	+262.1%	$5,174	0.0%	$0.89	17
2025-Q2	Decreased	1,600	-88.8%	$2,448	0.0%	$1.53	0
2025-Q1	New	14,311	—	$17,603	0.0%	$1.23	28
2024-Q4	Exited	0	-100.0%	$0	0.0%	$3.11	0
2024-Q3	New	19,104	—	$53,873	0.0%	$2.82	32